Last synced on 14 November 2025 at 11:06 pm

Immunoassay Blood Test For Amyloid Pathology Assessment

Page Type
Product Code
Definition
An Immunoassay blood test for amyloid pathology assessment is an in vitro diagnostic test used to identify patients with amyloid pathology associated with Alzheimer’s Disease who have signs and symptoms of cognitive decline. The results of the test are to be interpreted in conjunction with other patient clinical information.
Physical State
In vitro diagnostic device
Technical Method
Immunoassay
Target Area
Human blood specimens
Regulation Medical Specialty
Immunology
Review Panel
Immunology
Submission Type
510(K)
Device Classification
Class 2
Regulation Number
866.5840
GMP Exempt?
No
Summary Malfunction Reporting
Ineligible
Implanted Device
No
Life-Sustain/Support Device
No
Third Party Review
Not Third Party Eligible

No Linked CFR Text

Product code SET is linked to regulation 21CFR866.5840, which does not seem to exist yet. It may be pending at the moment.

Immunoassay Blood Test For Amyloid Pathology Assessment

Page Type
Product Code
Definition
An Immunoassay blood test for amyloid pathology assessment is an in vitro diagnostic test used to identify patients with amyloid pathology associated with Alzheimer’s Disease who have signs and symptoms of cognitive decline. The results of the test are to be interpreted in conjunction with other patient clinical information.
Physical State
In vitro diagnostic device
Technical Method
Immunoassay
Target Area
Human blood specimens
Regulation Medical Specialty
Immunology
Review Panel
Immunology
Submission Type
510(K)
Device Classification
Class 2
Regulation Number
866.5840
GMP Exempt?
No
Summary Malfunction Reporting
Ineligible
Implanted Device
No
Life-Sustain/Support Device
No
Third Party Review
Not Third Party Eligible

No Linked CFR Text

Product code SET is linked to regulation 21CFR866.5840, which does not seem to exist yet. It may be pending at the moment.